+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Cannabis Pharmaceuticals - Global Strategic Business Report - Product Thumbnail Image

Cannabis Pharmaceuticals - Global Strategic Business Report

  • Report
  • September 2026
  • 116 Pages
  • Global
From
Cardiovascular Clinical Trials - Global Strategic Business Report - Product Thumbnail Image

Cardiovascular Clinical Trials - Global Strategic Business Report

  • Report
  • September 2026
  • 393 Pages
  • Global
From
Critical Limb Ischemia Treatment - Global Strategic Business Report - Product Thumbnail Image

Critical Limb Ischemia Treatment - Global Strategic Business Report

  • Report
  • September 2026
  • 375 Pages
  • Global
From
Erectile Dysfunction Drugs - Global Strategic Business Report - Product Thumbnail Image

Erectile Dysfunction Drugs - Global Strategic Business Report

  • Report
  • September 2026
  • 287 Pages
  • Global
From
Montelukast Sodium - Global Strategic Business Report - Product Thumbnail Image

Montelukast Sodium - Global Strategic Business Report

  • Report
  • September 2026
  • 278 Pages
  • Global
From
From
GLP-1 Receptor Agonist - Global Strategic Business Report - Product Thumbnail Image

GLP-1 Receptor Agonist - Global Strategic Business Report

  • Report
  • September 2026
  • 483 Pages
  • Global
From
From
Caffeine Supplements - Global Strategic Business Report - Product Thumbnail Image

Caffeine Supplements - Global Strategic Business Report

  • Report
  • September 2026
  • 207 Pages
  • Global
From
Naltrexone and Buprenorphine - Global Strategic Business Report - Product Thumbnail Image

Naltrexone and Buprenorphine - Global Strategic Business Report

  • Report
  • September 2026
  • 364 Pages
  • Global
From
From
Neurology Clinical Trials - Global Strategic Business Report - Product Thumbnail Image

Neurology Clinical Trials - Global Strategic Business Report

  • Report
  • September 2026
  • 385 Pages
  • Global
From
Opioid Use Disorder - Global Strategic Business Report - Product Thumbnail Image

Opioid Use Disorder - Global Strategic Business Report

  • Report
  • September 2026
  • 177 Pages
  • Global
From
Erdosteine - Global Strategic Business Report - Product Thumbnail Image

Erdosteine - Global Strategic Business Report

  • Report
  • September 2026
  • 274 Pages
  • Global
From
Encephalitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Encephalitis Treatment - Global Strategic Business Report

  • Report
  • September 2026
  • 478 Pages
  • Global
From
Prediabetes Market - Global Strategic Business Report - Product Thumbnail Image

Prediabetes Market - Global Strategic Business Report

  • Report
  • September 2026
  • 287 Pages
  • Global
From
Morphine Drugs - Global Strategic Business Report - Product Thumbnail Image

Morphine Drugs - Global Strategic Business Report

  • Report
  • September 2026
  • 469 Pages
  • Global
From
Connective Tissue Diseases - Global Strategic Business Report - Product Thumbnail Image

Connective Tissue Diseases - Global Strategic Business Report

  • Report
  • September 2026
  • 385 Pages
  • Global
From
Abortion Drugs - Global Strategic Business Report - Product Thumbnail Image

Abortion Drugs - Global Strategic Business Report

  • Report
  • September 2026
  • 280 Pages
  • Global
From
Anti-Retroviral Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Retroviral Drugs - Global Strategic Business Report

  • Report
  • September 2026
  • 280 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more